Edgewise Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, targeted, small molecule therapies for the treatment of devastating muscle disorders, today reported financial results for…